Abattis Bioceuticals (Abattis Bioceuticals) EBITDA Margin % : -371.93% (As of Sep. 2019)

Abattis Bioceuticals EBITDA Margin % Chart

Abattis Bioceuticals Annual Data
	Trend	Sep10	Sep11	Sep12	Sep13	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19
EBITDA Margin %		Get a 7-Day Free Trial					-6,307.25	-	-	-936,983.33	-811.85

Abattis Bioceuticals Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
EBITDA Margin %	Get a 7-Day Free Trial															-1,971,900.00	-91,800.00	-9,000.00	-553.13	-371.93

Competitive Comparison of Abattis Bioceuticals's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Abattis Bioceuticals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abattis Bioceuticals's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abattis Bioceuticals's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Abattis Bioceuticals's EBITDA Margin % falls into.

Abattis Bioceuticals EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Abattis Bioceuticals's EBITDA Margin % for the fiscal year that ended in Sep. 2019 is calculated as

Abattis Bioceuticals's EBITDA Margin % for the quarter that ended in Sep. 2019 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abattis Bioceuticals  (OTCPK:ATTBF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Abattis Bioceuticals EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Abattis Bioceuticals's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Abattis Bioceuticals (Abattis Bioceuticals) Business Description